AUTOIMMUNE INTERSTITIAL LUNG DISEASE ILD PANEL Test
Test Name: AUTOIMMUNE INTERSTITIAL LUNG DISEASE ILD PANEL Test
Components:
- ANA / ANF, IFA (HEP-2) Reflex to ENA Profile
- ANCA, IFA in dilutions
- ANTI CCP
- RA factor, serum
- ACE
Price: 2120.0 AED
Sample Condition: 3 mL (2 mL min.) serum from 1 SST. Ship refrigerated or frozen.
Report Delivery: Sample Mon through Sat by 11 am; Report Next day
Method: CMIA, IFA, Immunoblot, Immunoturbidimetry, Spectrophotometry
Test Type: Disorders of Respiratory System
Doctor: Physician, Chest Physician
Test Department: IMMUNOPATHOLOGY
Pre Test Information: No special preparation required
Test Details:
The AUTOIMMUNE INTERSTITIAL LUNG DISEASE (ILD) PANEL test is a diagnostic tool used to evaluate and diagnose autoimmune interstitial lung diseases. This panel includes a combination of specific blood tests that help identify antibodies and markers associated with various autoimmune conditions that can affect the lungs.
Some of the tests included in this panel may include:
- Antinuclear Antibodies (ANA): This test detects the presence of antibodies that target the nucleus of cells. ANA can be found in various autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and scleroderma.
- Rheumatoid Factor (RF): This test measures the presence of antibodies directed against the Fc portion of immunoglobulin G (IgG). It is commonly used to diagnose rheumatoid arthritis but can also be elevated in other autoimmune conditions.
- Anti-Jo-1 Antibodies: This test detects the presence of antibodies against Jo-1, an enzyme found in the cytoplasm of cells. Elevated levels of anti-Jo-1 antibodies are associated with autoimmune conditions like polymyositis and dermatomyositis, which can affect the lungs.
- Anti-CCP Antibodies: This test detects the presence of antibodies against cyclic citrullinated peptides (CCP). Elevated levels of anti-CCP antibodies are highly specific for rheumatoid arthritis and can be associated with lung involvement.
- Anti-SSA and Anti-SSB Antibodies: These tests detect the presence of antibodies against Sjgren’s syndrome A (SSA) and Sjgren’s syndrome B (SSB) antigens. These antibodies are often found in patients with Sjgren’s syndrome, an autoimmune disease that can cause lung involvement.
- Anti-MDA5 Antibodies: This test detects the presence of antibodies against melanoma differentiation-associated protein 5 (MDA5). Elevated levels of anti-MDA5 antibodies are associated with dermatomyositis and can be associated with lung involvement.
These are just a few examples of the tests that may be included in the AUTOIMMUNE INTERSTITIAL LUNG DISEASE (ILD) PANEL. The specific tests ordered may vary depending on the suspected autoimmune condition and the patient’s symptoms and medical history. The results of these tests can help guide the diagnosis and treatment of autoimmune interstitial lung diseases.
Test Name | AUTOIMMUNE INTERSTITIAL LUNG DISEASE ILD PANEL Test |
---|---|
Components | *ANA / ANF, IFA (HEP-2) Reflexto ENA Profile*ANCA, IFA in dilutions *ANTI CCP*RA factor, serum *ACE |
Price | 2120.0 AED |
Sample Condition | 3 mL (2 mL min.) serum from 1 SST. Ship refrigerated or frozen. |
Report Delivery | Sample Mon through Sat by 11 am; Report Next day |
Method | CMIA, IFA, Immunoblot, Immunoturbidimetry, Spectrophotometry |
Test type | Disorders of Respiratory System |
Doctor | Physician, Chest Physician |
Test Department: | IMMUNOPATHOLOGY |
Pre Test Information | No special preparation required |
Test Details |
The AUTOIMMUNE INTERSTITIAL LUNG DISEASE (ILD) PANEL test is a diagnostic tool used to evaluate and diagnose autoimmune interstitial lung diseases. This panel includes a combination of specific blood tests that help identify antibodies and markers associated with various autoimmune conditions that can affect the lungs. Some of the tests included in this panel may include: 1. Antinuclear Antibodies (ANA): This test detects the presence of antibodies that target the nucleus of cells. ANA can be found in various autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and scleroderma. 2. Rheumatoid Factor (RF): This test measures the presence of antibodies directed against the Fc portion of immunoglobulin G (IgG). It is commonly used to diagnose rheumatoid arthritis but can also be elevated in other autoimmune conditions. 3. Anti-Jo-1 Antibodies: This test detects the presence of antibodies against Jo-1, an enzyme found in the cytoplasm of cells. Elevated levels of anti-Jo-1 antibodies are associated with autoimmune conditions like polymyositis and dermatomyositis, which can affect the lungs. 4. Anti-CCP Antibodies: This test detects the presence of antibodies against cyclic citrullinated peptides (CCP). Elevated levels of anti-CCP antibodies are highly specific for rheumatoid arthritis and can be associated with lung involvement. 5. Anti-SSA and Anti-SSB Antibodies: These tests detect the presence of antibodies against Sjgren’s syndrome A (SSA) and Sjgren’s syndrome B (SSB) antigens. These antibodies are often found in patients with Sjgren’s syndrome, an autoimmune disease that can cause lung involvement. 6. Anti-MDA5 Antibodies: This test detects the presence of antibodies against melanoma differentiation-associated protein 5 (MDA5). Elevated levels of anti-MDA5 antibodies are associated with dermatomyositis and can be associated with lung involvement. These are just a few examples of the tests that may be included in the AUTOIMMUNE INTERSTITIAL LUNG DISEASE (ILD) PANEL. The specific tests ordered may vary depending on the suspected autoimmune condition and the patient’s symptoms and medical history. The results of these tests can help guide the diagnosis and treatment of autoimmune interstitial lung diseases. |